Cytokinetics Inc (CYTK)
Current ratio
Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 | Mar 31, 2020 | ||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Total current assets | US$ in thousands | 1,107,940 | 1,018,600 | 1,067,810 | 638,704 | 628,051 | 561,416 | 586,575 | 680,629 | 795,186 | 884,275 | 602,250 | 623,526 | 535,672 | 494,941 | 364,229 | 433,117 | 474,221 | 418,412 | 218,954 | 225,938 |
Total current liabilities | US$ in thousands | 179,674 | 109,812 | 102,777 | 88,855 | 102,678 | 77,723 | 65,617 | 75,220 | 84,617 | 76,496 | 66,843 | 66,847 | 71,860 | 80,868 | 61,766 | 35,930 | 31,199 | 27,573 | 22,696 | 20,741 |
Current ratio | 6.17 | 9.28 | 10.39 | 7.19 | 6.12 | 7.22 | 8.94 | 9.05 | 9.40 | 11.56 | 9.01 | 9.33 | 7.45 | 6.12 | 5.90 | 12.05 | 15.20 | 15.17 | 9.65 | 10.89 |
December 31, 2024 calculation
Current ratio = Total current assets ÷ Total current liabilities
= $1,107,940K ÷ $179,674K
= 6.17
The current ratio of Cytokinetics Inc has fluctuated over the past few years, ranging from a high of 15.20 on December 31, 2020 to a low of 5.90 on June 30, 2021. The current ratio measures the company's ability to cover its short-term liabilities with its current assets. A higher current ratio is typically seen as favorable, indicating that the company has more than enough current assets to pay off its current liabilities.
It is important to note that a very high current ratio may suggest that the company is not efficiently utilizing its current assets, while a very low current ratio may indicate liquidity issues or an inability to meet short-term obligations.
Cytokinetics Inc's current ratio peaked at 15.20 on December 31, 2020, indicating a strong ability to cover its short-term liabilities with current assets at that time. However, the ratio then decreased significantly to 5.90 on June 30, 2021, which may have raised concerns about the company's liquidity position. Subsequently, the current ratio has shown some fluctuations but generally remained above 5, indicating a relatively healthy liquidity position.
Overall, the trend in Cytokinetics Inc's current ratio suggests that the company has had varying levels of liquidity over the past few years. Monitoring this ratio over time can provide insights into the company's financial health and ability to meet short-term obligations.
Peer comparison
Dec 31, 2024